Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells—Results From the SUCCESS A Trial-Reference-Cited by-同舟云学术

Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells—Results From the SUCCESS A Trial

Published:2018-10 Issue:5 Volume:18 Page:e1103-e1110
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Hepp Philip^ORCID,Fasching Peter A.,Beckmann Matthias W.,Fehm Tanja,Salmen Jessica,Hagenbeck Carsten,Jäger Bernadette,Widschwendter Peter^ORCID,de Gregorio Nikolaus,Schochter Fabienne,Mahner Sven,Harbeck Nadia,Weissenbacher Tobias,Kurt Ayse-Gül,Friedl Thomas W.P.,Janni Wolfgang,Rack Brigitte

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Breast cancer statistics, 2013;DeSantis;CA Cancer J Clin,2014

2. Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update;Smith;J Clin Oncol,2015

3. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours;Aapro;Eur J Cancer,2011

4. Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders;Touw;Front Biosci,2007

5. Circulating tumor cells predict survival in early average-to-high risk breast cancer patients;Rack;J Natl Cancer Inst,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-07-09

2. Current immunoassay methods and their applications to clinically used biomarkers of breast cancer;Clinical Biochemistry;2020-04